Cargando…

Liposomal phytohemagglutinin: In vivo T‐cell activator as a novel pan‐cancer immunotherapy

Immunotherapy is an attractive approach for treating cancer. T‐cell engagers (TCEs) are a type of immunotherapy that are highly efficacious; however, they are challenged by weak T‐cell activation and short persistence. Therefore, alternative solutions to induce greater activation and persistence of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alhallak, Kinan, Sun, Jennifer, Muz, Barbara, Jeske, Amanda, O’Neal, Julie, Ritchey, Julie K., Achilefu, Samuel, DiPersio, John F., Azab, Abdel Kareem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817130/ https://www.ncbi.nlm.nih.gov/pubmed/35014164 http://dx.doi.org/10.1111/jcmm.16885

Ejemplares similares

Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy
por: Alhallak, Kinan, et al.
Publicado: (2021)

Nanoparticle T cell engagers for the treatment of acute myeloid leukemia
por: Alhallak, Kinan, et al.
Publicado: (2021)

A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma
por: Alhallak, Kinan, et al.
Publicado: (2021)

Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma
por: Sun, Jennifer, et al.
Publicado: (2020)

Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma
por: Federico, Cinzia, et al.
Publicado: (2020)

Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges
por: Alhallak, Kinan, et al.
Publicado: (2021)

In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [(18)F]FDG and [(64)Cu]Cu-LLP2A PET
por: Ghai, Anchal, et al.
Publicado: (2021)

Selective targeting of histone modification fails to prevent graft versus host disease after hematopoietic cell transplantation
por: Alahmari, Bader, et al.
Publicado: (2018)

The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
por: Muz, Barbara, et al.
Publicado: (2015)

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival
por: Hathi, Deep, et al.
Publicado: (2022)

Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect
por: Choi, Jaebok, et al.
Publicado: (2014)

Molecularly Targeted Therapies in Multiple Myeloma
por: de la Puente, Pilar, et al.
Publicado: (2014)

Selinexor Overcomes Hypoxia-Induced Drug Resistance in Multiple Myeloma
por: Muz, Barbara, et al.
Publicado: (2017)

E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma
por: Maksimos, Mina, et al.
Publicado: (2023)

An ‘off-the-shelf’ fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
por: Cooper, Matthew L., et al.
Publicado: (2018)

Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease
por: Choi, Jaebok, et al.
Publicado: (2018)

A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity
por: Kim, Miriam Y., et al.
Publicado: (2022)

CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy
por: Kim, Miriam Y., et al.
Publicado: (2021)

THE EFFECTS OF ANTIGENS AND OF PHYTOHEMAGGLUTININ ON RABBIT SPLEEN CELL SUSPENSIONS
por: Harris, G., et al.
Publicado: (1966)

Characterization of DNA excreted from phytohemagglutinin-stimulated lymphocytes
Publicado: (1976)

THE EFFECTS OF THROMBIN ON PHYTOHEMAGGLUTININ RECEPTOR SITES IN HUMAN PLATELETS
por: Feagler, John R., et al.
Publicado: (1974)

Early swelling response to phytohemagglutinin is lower in older toads
por: Zamora-Camacho, Francisco Javier, et al.
Publicado: (2018)

CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies
por: Sun, Jennifer, et al.
Publicado: (2021)

Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib
por: Muz, Barbara, et al.
Publicado: (2015)

CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells
por: O’Neal, Julie, et al.
Publicado: (2022)

SPECIFIC INHIBITION BY RIFAMPICIN OF TRANSCRIPTION IN HUMAN LYMPHOCYTES STIMULATED BY PHYTOHEMAGGLUTININ
por: Pogo, Beatriz G. T.
Publicado: (1972)

The plant vacuolar protein, phytohemagglutinin, is transported to the vacuole of transgenic yeast
Publicado: (1987)

HEMOPOIETIC SPLEEN COLONY STUDIES : IV. PHYTOHEMAGGLUTININ AND HEMOPOIETIC REGENERATION
por: Curry, J. L., et al.
Publicado: (1967)

Synergistic and suppressive interactions among mouse T lymphocytes in the response to phytohemagglutinin
Publicado: (1975)

Phytohemagglutinin ameliorates HFD-induced obesity by increasing energy expenditure
por: Zhang, Yunxia, et al.
Publicado: (2021)

THE EFFECT OF PHYTOHEMAGGLUTININ ON RIBONUCLEIC ACID SYNTHESIS AND HISTONE ACETYLATION IN EQUINE LEUKOCYTES
por: Pogo, B. G. T., et al.
Publicado: (1967)

PHYTOHEMAGGLUTININ MITOGENIC PROTEINS : STRUCTURAL EVIDENCE FOR A FAMILY OF ISOMITOGENIC PROTEINS
por: Miller, J. Bruce, et al.
Publicado: (1973)

Neutrophil-to-Lymphocyte Ratio Is Associated with Impaired Interferon-Gamma Release to Phytohemagglutinin
por: Woo, Kwang-Sook, et al.
Publicado: (2015)

Spotlight on ixazomib: potential in the treatment of multiple myeloma
por: Muz, Barbara, et al.
Publicado: (2016)

Targeting E-selectin to Tackle Cancer Using Uproleselan
por: Muz, Barbara, et al.
Publicado: (2021)

Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc
por: O’Neal, Julie, et al.
Publicado: (2023)

STUDIES ON LYSOSOMES : XII. Redistribution of Acid Hydrolases in Human Lymphocytes Stimulated by Phytohemagglutinin
por: Hirschhorn, Rochelle, et al.
Publicado: (1968)

QUANTITATIVE STUDIES OF PHYTOHEMAGGLUTININ-INDUCED DNA AND RNA SYNTHESIS IN NORMAL AND AGAMMAGLOBULINEMIC LEUKOCYTES
por: Tormey, Douglass C., et al.
Publicado: (1967)

Phytohemagglutinin-induced differentiation and blastogenesis of precursor T cells from mouse bone marrow
Publicado: (1977)

The Significance Application of Indigenous Phytohemagglutinin (PHA) Mitogen on Metaphase and Cell Culture Procedure
por: Movafagh, Abolfazl, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9chm6j4tbg0t3ficovg0tkgqlb